L-Gulonolactone
|
Basic information |
| Metabolite name | L-Gulonolactone |
 | HMDB0003466 |
 |
C01040 |
 |
439373 |
| Synonyms | L-gulono-1,4-lactone; |
| No. of studies | 3 |
|
Basic information |
| Metabolite name | L-Gulonolactone |
| HMDB0003466 |
|
C01040 |
|
439373 |
| Synonyms | L-gulono-1,4-lactone; |
| No. of studies | 3 |
|
Relationship between L-Gulonolactone and depression (count: 3) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M1061 | Type1 | CUMS group vs. control group | Faece | Sprague-Dawley rat | Down |
| Study M1097 | Type1 | placebo-treated depression group vs. control group | Faece | Human | Up |
| Study M1097 | Type2 | probiotic-treated depression group vs. placebo-treated depression group | Faece | Human | Down |
| Study M981 | Type1 | Abeta oligomer group vs. control group | Serum | ICR mouse | Up |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running group vs. Abeta oligomer group | Serum | ICR mouse | Down |
| Study M981 | Type2 | Abeta oligomer + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Down |
| Study M981 | Type2 | Abeta oligomer + involuntary and voluntary running + acousto-optic stimulation group vs. Abeta oligomer group | Serum | ICR mouse | Down |